Viatris Unclassified
FDA Approved Drugs

Viatris Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 87
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
922
View
Unclassified
87
View
Discontinued
317
View
OTC
7
View
RX
511
View
Company Overview

Company

Viatris Unclassified

Country

U.S.A

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Viatris Unclassified

Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317

U.S.A

www.viatris.com/en HRServiceCenter@Viatris.com View on Map
FDA Approved Drug Records ( 87 records )
-
Unclassified Application: 200733

Drug Name

ABACAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

60 MG

Approval Date

-

200733 / 1

Active Ingredient

ABACAVIR SULFATE

Application Number

200733

Product Number

1

Dosage Form

-

Strength

60 MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90519

Drug Name

ABACAVIR SULFATE; LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

600MG; 300MG

Approval Date

-

90519 / 1

Active Ingredient

ABACAVIR SULFATE; LAMIVUDINE

Application Number

90519

Product Number

1

Dosage Form

-

Strength

600MG; 300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202381

Drug Name

ABACAVIR SULFATE; LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

60MG; 30MG

Approval Date

-

202381 / 1

Active Ingredient

ABACAVIR SULFATE; LAMIVUDINE

Application Number

202381

Product Number

1

Dosage Form

-

Strength

60MG; 30MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 86010

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

86010 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

86010

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 86011

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

-

86011 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

86011

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 86153

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

86153 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

86153

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 86157

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

86157 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

86157

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 86158

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

86158 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

86158

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90398

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

1

Dosage Form

-

Strength

5MG/20MG

Approval Date

-

90398 / 1

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

90398

Product Number

1

Dosage Form

-

Strength

5MG/20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90398

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

2

Dosage Form

-

Strength

5MG/40MG

Approval Date

-

90398 / 2

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

90398

Product Number

2

Dosage Form

-

Strength

5MG/40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90398

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

3

Dosage Form

-

Strength

10MG/20MG

Approval Date

-

90398 / 3

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

90398

Product Number

3

Dosage Form

-

Strength

10MG/20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90398

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

4

Dosage Form

-

Strength

10MG/40MG

Approval Date

-

90398 / 4

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

90398

Product Number

4

Dosage Form

-

Strength

10MG/40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91611

Drug Name

ATAZANAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

91611 / 1

Active Ingredient

ATAZANAVIR SULFATE

Application Number

91611

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22282

Drug Name

ATAZANAVIR SULFATE AND RITONAVIR

Product Number

1

Dosage Form

-

Strength

300MG/100MG

Approval Date

-

22282 / 1

Active Ingredient

ATAZANAVIR SULFATE; RITONAVIR

Application Number

22282

Product Number

1

Dosage Form

-

Strength

300MG/100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 206909

Drug Name

BALSALAZIDE DISODIUM

Product Number

1

Dosage Form

-

Strength

1.1G

Approval Date

-

206909 / 1

Active Ingredient

BALSALAZIDE DISODIUM

Application Number

206909

Product Number

1

Dosage Form

-

Strength

1.1G

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 71296

Drug Name

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;5MG

Approval Date

-

71296 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Application Number

71296

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 201824

Drug Name

CLOZAPINE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

201824 / 1

Active Ingredient

CLOZAPINE

Application Number

201824

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 209847

Drug Name

DARUNAVIR AND RITONAVIR

Product Number

1

Dosage Form

-

Strength

400MG/50MG

Approval Date

-

209847 / 1

Active Ingredient

DARUNAVIR AND RITONAVIR

Application Number

209847

Product Number

1

Dosage Form

-

Strength

400MG/50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 209670

Drug Name

DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

50MG;300MG;300MG

Approval Date

-

209670 / 1

Active Ingredient

DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE

Application Number

209670

Product Number

1

Dosage Form

-

Strength

50MG;300MG;300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70790

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

70790 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

70790

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70792

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

-

70792 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

70792

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70793

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

70793 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

70793

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90855

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

90855 / 1

Active Ingredient

DOXYCYCLINE

Application Number

90855

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22461

Drug Name

EFAVIRENZ

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

22461 / 1

Active Ingredient

EFAVIRENZ

Application Number

22461

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22461

Drug Name

EFAVIRENZ

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

22461 / 2

Active Ingredient

EFAVIRENZ

Application Number

22461

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22461

Drug Name

EFAVIRENZ

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

22461 / 3

Active Ingredient

EFAVIRENZ

Application Number

22461

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213509

Drug Name

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

1

Dosage Form

-

Strength

400MG; 200MG; 25MG

Approval Date

-

213509 / 1

Active Ingredient

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

213509

Product Number

1

Dosage Form

-

Strength

400MG; 200MG; 25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90437

Drug Name

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

600MG; 200MG; 300MG

Approval Date

-

90437 / 1

Active Ingredient

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

90437

Product Number

1

Dosage Form

-

Strength

600MG; 200MG; 300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90488

Drug Name

EMTRICITABINE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

-

90488 / 1

Active Ingredient

EMTRICITABINE

Application Number

90488

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90049

Drug Name

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

200MG; 300MG

Approval Date

-

90049 / 1

Active Ingredient

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

90049

Product Number

1

Dosage Form

-

Strength

200MG; 300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204004

Drug Name

EPZICOM

Product Number

1

Dosage Form

-

Strength

600MG;300MG

Approval Date

-

204004 / 1

Active Ingredient

ABACAVIR;LAMIVUDINE

Application Number

204004

Product Number

1

Dosage Form

-

Strength

600MG;300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20167

Drug Name

ESTRADIOL

Product Number

1

Dosage Form

-

Strength

0.025MG/DAY

Approval Date

-

20167 / 1

Active Ingredient

ESTRADIOL

Application Number

20167

Product Number

1

Dosage Form

-

Strength

0.025MG/DAY

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20167

Drug Name

ESTRADIOL

Product Number

2

Dosage Form

-

Strength

0.0375MG/DAY

Approval Date

-

20167 / 2

Active Ingredient

ESTRADIOL

Application Number

20167

Product Number

2

Dosage Form

-

Strength

0.0375MG/DAY

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20167

Drug Name

ESTRADIOL

Product Number

3

Dosage Form

-

Strength

0.05MG/DAY

Approval Date

-

20167 / 3

Active Ingredient

ESTRADIOL

Application Number

20167

Product Number

3

Dosage Form

-

Strength

0.05MG/DAY

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20167

Drug Name

ESTRADIOL

Product Number

4

Dosage Form

-

Strength

0.075MG/DAY

Approval Date

-

20167 / 4

Active Ingredient

ESTRADIOL

Application Number

20167

Product Number

4

Dosage Form

-

Strength

0.075MG/DAY

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20167

Drug Name

ESTRADIOL

Product Number

5

Dosage Form

-

Strength

0.1MG/DAY

Approval Date

-

20167 / 5

Active Ingredient

ESTRADIOL

Application Number

20167

Product Number

5

Dosage Form

-

Strength

0.1MG/DAY

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 75233

Drug Name

ESTRADIOL

Product Number

1

Dosage Form

-

Strength

0.05MG/24HR

Approval Date

-

75233 / 1

Active Ingredient

ESTRADIOL

Application Number

75233

Product Number

1

Dosage Form

-

Strength

0.05MG/24HR

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

1

Dosage Form

-

Strength

100MCG

Approval Date

-

202577 / 1

Active Ingredient

FENTANYL

Application Number

202577

Product Number

1

Dosage Form

-

Strength

100MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

2

Dosage Form

-

Strength

200MCG

Approval Date

-

202577 / 2

Active Ingredient

FENTANYL

Application Number

202577

Product Number

2

Dosage Form

-

Strength

200MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

3

Dosage Form

-

Strength

300MCG

Approval Date

-

202577 / 3

Active Ingredient

FENTANYL

Application Number

202577

Product Number

3

Dosage Form

-

Strength

300MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

4

Dosage Form

-

Strength

400MCG

Approval Date

-

202577 / 4

Active Ingredient

FENTANYL

Application Number

202577

Product Number

4

Dosage Form

-

Strength

400MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

5

Dosage Form

-

Strength

600MCG

Approval Date

-

202577 / 5

Active Ingredient

FENTANYL

Application Number

202577

Product Number

5

Dosage Form

-

Strength

600MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202577

Drug Name

FENTANYL

Product Number

6

Dosage Form

-

Strength

800MCG

Approval Date

-

202577 / 6

Active Ingredient

FENTANYL

Application Number

202577

Product Number

6

Dosage Form

-

Strength

800MCG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76538

Drug Name

FEXOFENADINE HCL; PSEUDOEPHEDRINE HCL

Product Number

1

Dosage Form

-

Strength

60/120MG

Approval Date

-

76538 / 1

Active Ingredient

FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

76538

Product Number

1

Dosage Form

-

Strength

60/120MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761154

Drug Name

HULIO

Product Number

1

Dosage Form

-

Strength

20MG;0.4ML

Approval Date

-

761154 / 1

Active Ingredient

ADALIMUMAB-FKJP

Application Number

761154

Product Number

1

Dosage Form

-

Strength

20MG;0.4ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202171

Drug Name

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

300MG; 300MG; 200MG

Approval Date

-

202171 / 1

Active Ingredient

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE

Application Number

202171

Product Number

1

Dosage Form

-

Strength

300MG; 300MG; 200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 200748

Drug Name

LAMIVUDINE; ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

200748 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE

Application Number

200748

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204914

Drug Name

LAMIVUDINE; ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

204914 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE

Application Number

204914

Product Number

1

Dosage Form

-

Strength

30MG; 60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

1

Dosage Form

-

Strength

0.025MG

Approval Date

-

76764 / 1

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

1

Dosage Form

-

Strength

0.025MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

2

Dosage Form

-

Strength

0.050MG

Approval Date

-

76764 / 2

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

2

Dosage Form

-

Strength

0.050MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

3

Dosage Form

-

Strength

0.075MG

Approval Date

-

76764 / 3

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

3

Dosage Form

-

Strength

0.075MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

4

Dosage Form

-

Strength

0.088MG

Approval Date

-

76764 / 4

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

4

Dosage Form

-

Strength

0.088MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

5

Dosage Form

-

Strength

0.1MG

Approval Date

-

76764 / 5

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

5

Dosage Form

-

Strength

0.1MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

6

Dosage Form

-

Strength

0.112MG

Approval Date

-

76764 / 6

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

6

Dosage Form

-

Strength

0.112MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

7

Dosage Form

-

Strength

0.125MG

Approval Date

-

76764 / 7

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

7

Dosage Form

-

Strength

0.125MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

8

Dosage Form

-

Strength

0.15MG

Approval Date

-

76764 / 8

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

8

Dosage Form

-

Strength

0.15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

9

Dosage Form

-

Strength

0.175MG

Approval Date

-

76764 / 9

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

9

Dosage Form

-

Strength

0.175MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

10

Dosage Form

-

Strength

0.2MG

Approval Date

-

76764 / 10

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

10

Dosage Form

-

Strength

0.2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 76764

Drug Name

LEVOTHYROXINE SODIUM

Product Number

11

Dosage Form

-

Strength

0.3MG

Approval Date

-

76764 / 11

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

76764

Product Number

11

Dosage Form

-

Strength

0.3MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208430

Drug Name

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG;500MG

Approval Date

-

208430 / 1

Active Ingredient

LINAGLIPTIN;METFORMIN HYDROCHLORIDE

Application Number

208430

Product Number

1

Dosage Form

-

Strength

2.5MG;500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208430

Drug Name

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

2.5MG;850MG

Approval Date

-

208430 / 2

Active Ingredient

LINAGLIPTIN;METFORMIN HYDROCHLORIDE

Application Number

208430

Product Number

2

Dosage Form

-

Strength

2.5MG;850MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208430

Drug Name

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

2.5MG;1GM

Approval Date

-

208430 / 3

Active Ingredient

LINAGLIPTIN;METFORMIN HYDROCHLORIDE

Application Number

208430

Product Number

3

Dosage Form

-

Strength

2.5MG;1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70075

Drug Name

METHYLDOPA

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

-

70075 / 1

Active Ingredient

METHYLDOPA

Application Number

70075

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205367

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

205367 / 1

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205367

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205367

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

205367 / 2

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205367

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205367

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

205367 / 3

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205367

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205367

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

205367 / 4

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205367

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 75073

Drug Name

NITROGLYCERIN

Product Number

1

Dosage Form

-

Strength

0.2MG/HR

Approval Date

-

75073 / 1

Active Ingredient

NITROGLYCERIN

Application Number

75073

Product Number

1

Dosage Form

-

Strength

0.2MG/HR

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 75075

Drug Name

NITROGLYCERIN

Product Number

1

Dosage Form

-

Strength

0.4MG/HR

Approval Date

-

75075 / 1

Active Ingredient

NITROGLYCERIN

Application Number

75075

Product Number

1

Dosage Form

-

Strength

0.4MG/HR

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 75076

Drug Name

NITROGLYCERIN

Product Number

1

Dosage Form

-

Strength

0.1MG/HR

Approval Date

-

75076 / 1

Active Ingredient

NITROGLYCERIN

Application Number

75076

Product Number

1

Dosage Form

-

Strength

0.1MG/HR

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78293

Drug Name

Oxybutynin Chloride

Product Number

1

Dosage Form

-

Strength

15 MG.

Approval Date

-

78293 / 1

Active Ingredient

Oxybutynin Chloride

Application Number

78293

Product Number

1

Dosage Form

-

Strength

15 MG.

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216228

Drug Name

PALIPERIDONE PALMITATE

Product Number

1

Dosage Form

-

Strength

273MG/0.88ML

Approval Date

-

216228 / 1

Active Ingredient

PALIPERIDONE PALMITATE

Application Number

216228

Product Number

1

Dosage Form

-

Strength

273MG/0.88ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70336

Drug Name

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG;2MG

Approval Date

-

70336 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Application Number

70336

Product Number

1

Dosage Form

-

Strength

10MG;2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70337

Drug Name

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG;2MG

Approval Date

-

70337 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Application Number

70337

Product Number

1

Dosage Form

-

Strength

25MG;2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 70338

Drug Name

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG;4MG

Approval Date

-

70338 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Application Number

70338

Product Number

1

Dosage Form

-

Strength

25MG;4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 71442

Drug Name

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG;4MG

Approval Date

-

71442 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Application Number

71442

Product Number

1

Dosage Form

-

Strength

10MG;4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 72573

Drug Name

PRAZOSIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

-

72573 / 1

Active Ingredient

PRAZOSIN HYDROCHLORIDE

Application Number

72573

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 72574

Drug Name

PRAZOSIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

-

72574 / 1

Active Ingredient

PRAZOSIN HYDROCHLORIDE

Application Number

72574

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202738

Drug Name

RITONAVIR

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

202738 / 1

Active Ingredient

RITONAVIR

Application Number

202738

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212220

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

-

212220 / 1

Active Ingredient

RIVAROXABAN

Application Number

212220

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210605

Drug Name

SEMGLEE

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

210605 / 1

Active Ingredient

INSULIN GLARGINE

Application Number

210605

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761201

Drug Name

SEMGLEE

Product Number

1

Dosage Form

-

Strength

10ML(100UNITS/ML)

Approval Date

-

761201 / 1

Active Ingredient

INSULIN GLARGINE-YFGN

Application Number

761201

Product Number

1

Dosage Form

-

Strength

10ML(100UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761201

Drug Name

SEMGLEE

Product Number

2

Dosage Form

-

Strength

3ML(100UNITS/ML)

Approval Date

-

761201 / 2

Active Ingredient

INSULIN GLARGINE-YFGN

Application Number

761201

Product Number

2

Dosage Form

-

Strength

3ML(100UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202473

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

202473 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202473

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202473

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

-

202473 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202473

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202473

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

202473 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202473

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 73038

Drug Name

SULINDAC

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

73038 / 1

Active Ingredient

SULINDAC

Application Number

73038

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    55 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    41 View
  • FDA Approved Drugs Database
    922 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
87 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABACAVIR SULFATE

Application Number

200733

Product Number

1

Active Ingredient

ABACAVIR SULFATE

Dosage Form

-

Strength

60 MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.